Childhood Medulloblastoma — Trials

Childhood Medulloblastoma — Trials · CancerIndex

Clinical trials

Registered studies

56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 12
Ph III recruiting: 2
Growth YoY: —
Industry share: 0%
Top sponsor: Aron Onerup
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01869725	Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT	completed	Phase 2	68	Sue O'DorisioOTHER	1	Sep 22, 2021	clinicaltrials
NCT00381797	Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma	completed	Phase 2	97	National Cancer Institute (NCI)NIH	1	Nov 28, 2017	clinicaltrials